Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wang, Z.
Right arrow Articles by Vaziri, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Z.
Right arrow Articles by Vaziri, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 13, Issue 12 3052-3057, Copyright © 1998 by Oxford University Press


ORIGINAL ARTICLES

Effect of heparin on mesangial cell growth and gene expression of matrix proteins

Z Wang, K Liang, M Pahl and N Vaziri
Division of Nephrology, Department of Medicine, University of California, Irvine, CA, USA; Corresponding author address: Division of Nephrology, UCI Medical Centre, 101 The City Drive, Orange, CA 92868, USA

Background. Mesangial cell (MC) proliferation and matrix expansion are characteristics of many glomerulopathies. Heparin has been shown to inhibit MC proliferation in vitro and mitigate cell proliferation, matrix expansion, proteinuria, renal insufficiency, and hypertension in experimental glomerulonephritis and subtotal renal ablation. We examined the effect of standard heparin on MC proliferation and matrix protein expression in vitro which necessarily excludes the confounding influences of haemodynamic, inflammatory, heamostatic, and various other processes that are present in vivo. Methods. Gene expression and release of fibronectin (FN), collagen IV and laminin by cultured rat MC were tested in the presence and absence of heparin. In addition the effect of transforming growth factor-{beta}1 (TGF-{beta}1) on the gene expression of those matrix proteins was assessed. Results. Within a 3-1000 &mgr;g/ml concentration range, heparin inhibited gene expression and release of FN by 10% fetal calf serum (FCS)-stimulated MC in a concentration-dependent manner. At concentrations of 300 and 1000 &mgr;g/ml, heparin inhibited fibronectin mRNA levels in TGF-{beta}1 (6 ng/ml) stimulated cells. However, heparin had no effect on gene expression or release of collagen IV or laminin under these conditions. Heparin markedly inhibited 10% FCS-stimulated MC proliferation in a concentration-dependent manner. Conclusions. Heparin inhibited MC growth and fibronectin production. These effects may, in part, account for the reported beneficial effects of heparin on the course of renal disease in experimental animals. Keywords: collagen, laminin, fibronectin, TGF-{beta}1
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
S. M. Smorenburg and C. J. F. Van Noorden
The Complex Effects of Heparins on Cancer Progression and Metastasis in Experimental Studies
Pharmacol. Rev., March 1, 2001; 53(1): 93 - 106.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. CEOL, G. GAMBARO, U. SAUER, B. BAGGIO, F. ANGLANI, M. FORINO, S. FACCHIN, L. BORDIN, C. WEIGERT, A. NERLICH, et al.
Glycosaminoglycan Therapy Prevents TGF-{beta}1 Overexpression and Pathologic Changes in Renal Tissue of Long-Term Diabetic Rats
J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2324 - 2336.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.